Vascular Closure Devices Market Size Worth USD 1.9 Billion by 2030 at 7.30% CAGR – Report by Market Research Future (MRFR)

Vascular Closure Devices Market Size Worth USD 1.9 Billion by 2030 at 7.30% CAGR - Report by Market Research Future (MRFR)

Market Drivers:

Vascular diseases have become a critical healthcare issue across the globe, with the burden surging at an alarming speed owing to bad eating habits, lack of exercise, and a host of environmental factors. Despite the United States being a developed country with well-developed healthcare industry, the disease burden is as prevalent as six in every ten individuals. With the dramatic surge in cases and the growing hospital admissions, the need for effective vascular closure devices has been rising as well. The surge in technical advances in medical technologies, the expanding geriatric pool, and the escalating preference for minimally or non-invasive surgeries are also responsible for the burgeoning market size.

Mounting angioplasty procedures and increasing product approval by authoritative agencies seem to be working in favor of the vascular closure devices industry. Innovations in bioresorbable vascular closure devices combined with the increased focus on emerging regions that are brimming with significant growth potential are a few lucrative opportunities that the top firms are expected to be presented with.

On the bright side, the global vascular stents market has a rich vendor landscape and this has given way to an intense level of competition. With many of the companies actively looking for growth measures to capture a higher share, it is anticipated that the global market could observe smooth progress throughout the review period. Some of the key growth tactics taken up by the companies include collaborations, mergers, and product development and launch along with acquisitions.

Market Restraints:

The global market has been riding high on the back of the rising prevalence of cardiovascular diseases and the strong government support for the healthcare industry.

With that said, the rise in product recalls as well as failures can be huge challenges for the global market over the evaluation period, slowing down the growth rate to some extent.

Browse In-depth Market Research Report (160 Pages) on Vascular Closure Devices: https://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704

Vascular Closure Devices Market COVID 19 Analysis

The COVID-19 outbreak’s notable impact has led to various repercussions on the health status of people across the world. The aftermath is linked with the significant social and economic burden on people worldwide. While the major policymakers are implementing new frameworks and industries are adopting advanced models of expansion to maintain their relevance, people are facing a series of mental trauma.

Around the world, the rising cases have spurred mental, and economic issues, especially among the elderly. Additionally, the younger populace has been dealing with challenges owing to loss of livelihoods and is opting for family care to address the repercussions. The focus is largely on the treatment of COVID-19 and the development of a vaccine, which steers attention away from other markets. However, the demand for advanced medical devices with high efficiency has risen considerably, which should greatly benefit the global industry in the long run.

Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=5704

Vascular Closure Devices Market Segmentation

By Product Type

The vascular closure devices industry, with respect to product type, can be categorized into active vascular closure devices, external hemostatic devices, and passive vascular closure devices. The types of passive vascular closure devices are sealant or gel-based devices, compression assist devices, and plug-based devices. The active vascular closure device types are suture-based devices, gamma-retroviral vectors, and clip-based devices.

Vascular Closure Devices Market Regional Insights

The Americas can be the most attractive market in the years ahead, as the need for vascular closure devices has been increasing in line with the rising cases and the high uptake of advanced technologies. High demand for minimally invasive procedures in Canada and the US can be another key growth rendering factor in the regional market. Sizeable investments in various medical research activities, favorable government policies, successful treatments, and early diagnosis rates are a few other factors that encourage market growth in the region.

The APAC market could observe consistent growth throughout the analysis period, thanks to the rising prominence of the vascular disease combined with the rapidly burgeoning elderly population. Other key contributing factors could be the escalating cases of cardiovascular diseases, increased consumption of modern technologies, and the cheaper manufacturing costs pertaining to medical devices.

Discover more research reports on Healthcare Industry, by Market Research Future:

Multiple Myeloma Treatment Market Trends, Insights and Size Analysis By Treatment (Chemotherapy, Radiation Therapy, Stem Cell Transplant, Corticosteroids, Interferon, and Others), End User (Hospitals, Clinics, Independent Pharmacies, and Others)—Forecast till 2027

Keloid Treatment Market Research Report: By Product (Elastic Wraps, Ointment), by Treatment (Radiation Therapy, Cry Therapy, Surgical Treatment, Laser Treatment, Laser Treatment, Interferon), by End-User (Hospitals and Others)—Forecast till 2030

Neuroprosthetics Market Research Report, by Type (Cognitive Prosthetics, Cochlear Implant), Techniques (Vagus Nerve Stimulation), Application (Motor Neuron Disorders) End-User (Hospitals and Clinics, Diagnostic Centers)- Forecast till 2027

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Vascular Closure Devices Market Size to Reach USD 1.93 Billion by 2031 | Growth Forecasts & Insights

Vascular Closure Devices Market Size to Reach USD 1.93 Billion by 2031 | Growth Forecasts & Insights

Global Vascular Closure Devices market is undergoing accelerated growth as minimally invasive cardiovascular procedures become the clinical standard worldwide. Valued at USD 1,157 million in 2024, the market is expected to expand from USD 1,246 million in 2025 to USD 1,931 million by 2031, registering a robust CAGR of 7.8% over the forecast period. Rising procedural volumes, technological refinement in active closure systems, and increasing emphasis on faster patient recovery are reinforcing long-term market momentum.

Access the full briefing https://www.24lifesciences.com/vascular-closure-devices-market-8017

 

Emerging Healthcare Trends Shaping the Market

In 2025, vascular closure devices are benefiting from broader shifts in interventional cardiology and endovascular care. Healthcare systems are prioritizing minimally invasive treatment pathways, driven by shorter hospital stays, reduced complication rates, and improved patient satisfaction.

Advances in fully absorbable active closure technologies are improving safety profiles by eliminating intravascular remnants while delivering predictable hemostasis. Simultaneously, digital imaging, catheter-based precision tools, and standardized catheterization lab workflows are enhancing procedural efficiency. Regulatory focus on patient safety and post-procedural outcomes is further accelerating adoption of next-generation vascular closure solutions across hospitals and ambulatory settings.

 

Key Market Drivers Fueling Growth

  • Rising cardiovascular disease burden: Increasing prevalence of coronary artery disease and structural heart disorders is driving higher procedural demand.
  • Shift toward minimally invasive interventions: Procedures such as angioplasty, stent placement, and valve repair require reliable arterial closure.
  • Demand for faster patient ambulation: Hospitals prioritize devices that reduce recovery time and access-site complications.
  • Technological superiority over manual compression: Active closure devices deliver consistent outcomes with lower complication risks.

Together, these drivers position vascular closure devices as essential tools in modern interventional care.

Download detailed insight https://www.24lifesciences.com/download-sample/8017/vascular-closure-devices-market

 

Competitive Landscape: Leading Companies

The market features a competitive ecosystem of global medical device manufacturers focused on innovation, clinical performance, and geographic expansion. Key players include:

  • Abbott Laboratories – Advancing active vascular closure platforms designed for safety, speed, and physician control.
  • Terumo Corporation – Leveraging precision engineering to support complex interventional procedures globally.
  • Cordis (Cardinal Health) – Strengthening its cardiovascular portfolio with physician-focused closure technologies.
  • Teleflex Incorporated – Expanding access-site management solutions through continuous product refinement.
  • Morris Innovative – Contributing specialized closure technologies tailored for high-acuity interventions.

Strategic investments in R&D, clinical validation, and hospital partnerships remain central to competitive positioning.

 

Segment Insights & Regional Overview

Segment Analysis

By Type, 8F devices dominate the market, favored for their compatibility with larger arterial access required in complex cardiovascular interventions. Their proven ability to achieve rapid, reliable hemostasis reinforces their leadership in catheterization labs worldwide.

By Application, interventional procedures represent the largest segment, supported by growing volumes of angioplasty, stent placement, and valve repair surgeries. Effective arterial closure directly influences recovery outcomes and lab efficiency.

By End User, hospitals remain the primary adopters, driven by advanced infrastructure, multidisciplinary expertise, and standardized device protocols for high-acuity cases.

By Technology, active closure devices lead due to immediate, controlled closure using sutures, clips, or sealants. Fully absorbable systems are gaining preference for enhanced safety and comfort.

By Access Site, femoral artery access continues to dominate, particularly for procedures requiring larger sheath sizes, despite increasing interest in radial approaches.

Regional Highlights

  • North America leads the global market, supported by advanced healthcare infrastructure, strong reimbursement frameworks, and high interventional procedure volumes.
  • Europe represents a mature market with widespread adoption of minimally invasive techniques and strong regulatory oversight ensuring device quality.
  • Asia-Pacific is the fastest-growing region, fueled by expanding catheterization labs, rising healthcare investment, and increasing physician awareness.
  • South America shows emerging potential, led by Brazil, with gradual improvements in private healthcare access.
  • Middle East & Africa present long-term opportunities, particularly in GCC countries investing heavily in advanced cardiac care.

Explore the full findings https://www.24lifesciences.com/vascular-closure-devices-market-8017

 

Technological Advancements & Strategic Outlook

Can Advanced Active Closure Technologies Redefine Interventional Outcomes?

The transition from traditional compression methods to sophisticated active closure systems is reshaping access-site management. Innovations focused on absorbability, precision deployment, and reduced complication rates are expected to define future standards. As hospitals align with value-based care models, vascular closure devices will play a pivotal role in improving outcomes while optimizing procedural efficiency.

 

Key Benefits of the Report

  • Detailed market valuation and CAGR forecasts through 2031
  • Comprehensive segmentation by type, application, end user, technology, and access site
  • In-depth regional growth analysis and opportunity mapping
  • Competitive benchmarking of leading industry players
  • Strategic insights for investors, healthcare providers, and policymakers

View the extended analysis https://www.24lifesciences.com/vascular-closure-devices-market-8017

 

Future Perspective

As interventional cardiology continues its global shift toward minimally invasive care, the Vascular Closure Devices market is positioned for sustained, high-growth expansion. Continuous innovation, expanding procedural access, and rising cardiovascular disease prevalence will create compelling opportunities for stakeholders aligned with next-generation closure technologies.

Explore Life sciences Related Ongoing Coverage in Healthcare Domain:

Exelon Patch Market

IV Solution Bags Market

Membrane Oxygenator Market

Exonuclease I Market

Mouse IgG Market

Antibody Market 

Smart Vehicle CT Market

Cannabis Oil Market 

CT Machine Market 

Drug-eluting Microsphere Market

 

About 24lifesciences

Founded in 2017, 24LifeScience has emerged as a trusted research and analytics partner for organizations operating within the global life sciences and chemical industries. Our core mission is to provide intelligent, future-ready insights that help clients stay ahead in an increasingly complex and innovation-driven market

International: +1(332) 2424 294 | Asia: +91 9425150513 (Asia)

Website: http://www.24lifesciences.com                                          

Follow us on LinkedIn: http://www.linkedin.com/company/lifesciences24